publication . Article . 2018

Networking of Public Health Microbiology Laboratories Bolsters Europe's Defenses against Infectious Diseases.

Barbara Albiger; Joana Revez; Katrin Leitmeyer; Marc Struelens;
Open Access
  • Published: 26 Feb 2018
In an era of global health threats caused by epidemics of infectious diseases and rising multidrug resistance, microbiology laboratories provide essential scientific evidence for risk assessment, prevention, and control. Microbiology has been at the core of European infectious disease surveillance networks for decades. Since 2010, these networks have been coordinated by the European Centre for Disease Prevention and Control (ECDC). Activities delivered in these networks include harmonization of laboratory diagnostic, antimicrobial susceptibility and molecular typing methods, multicentre method validation, technical capacity mapping, training of laboratory staff,...
Persistent Identifiers
free text keywords: Public Health, Environmental and Occupational Health, Public Health, Perspective, public health laboratory networks, public health microbiology, external quality assessment, molecular diagnostics, antimicrobial susceptibility testing, molecular typing, communicable disease surveillance, emerging diseases, Global health, Public health, medicine.medical_specialty, medicine, Preparedness, Microbiology, Business, International health, business.industry, European union, media_common.cataloged_instance, media_common, eHealth, Infectious disease (medical specialty), One Health, lcsh:Public aspects of medicine, lcsh:RA1-1270
56 references, page 1 of 4

1 World Health Organization. International Health Regulations. 2nd ed Geneva: WHO (2005).

2 Mulders MN Rota PA Icenogle JP Brown KE Takeda M Rey GJ Global measles and rubella laboratory network support for elimination goals, 2010-2015. MMWR Morb Mortal Wkly Rep (2016) 65(17):438–42.10.15585/mmwr.mm6517a3 27148917 [OpenAIRE] [PubMed] [DOI]

3 Laszlo A Rahman M Espinal M Raviglione M WHO/IUATLD Network of Supranational Reference Laboratories. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998. Int J Tuberc Lung Dis (2002) 6(9):748–56.12234129 [PubMed]

4 European Commission. Regulation (EC) No 851/2004 of the European Parliament and of the Council of 21 April 2004 Establishing a European Centre for Disease Prevention and Control. Strasbourg: OJEU (2004). Available from:

5 European Commission. Decision No 1082/2013/EU of the European Parliament and of the Council of 22 October 2013 on Serious Cross-Border Threats to Health and Repealing Decision No 2119/98/EC Text with EEA Relevance (2013). Available from:

6 European Commission. Decision No 2012/506/EU. Commission Implementing Decision of 8 August 2012 Amending Decision 2002/253/EC Laying Down Case Definitions for Reporting Communicable Diseases to the Community Network under Decision No 2119/98/EC of the European Parliament and of the Council (2012). Available from:

7 European Centre for Disease Prevention and Control. EU Laboratory Capacity Monitoring System (EULabCap) – Report on 2015 Survey of EU/EEA Capabilities and Capacities. Stockholm: ECDC (2017). Ava ilable from:

8 Economisti Associati Srl. The Second Independent Evaluation of the ECDC in Accordance with its Founding Regulation (European Parliament and Council Regulation (EC) no 851/2004)Bologna (2014). Available from:

9 Nikolayevskyy V Hillemann D Richter E Ahmed N van der Werf MJ Kodmon C External quality assessment for tuberculosis diagnosis and drug resistance in the European Union: a five year multicentre implementation study. PLoS One (2016) 11(4):e0152926.10.1371/journal.pone.0152926 27055064 [OpenAIRE] [PubMed] [DOI]

10 de Beer JL Kodmon C van Ingen J Supply P van Soolingen D Global network for molecular surveillance of tuberculosis. Second worldwide proficiency study on variable number of tandem repeats typing of Mycobacterium tuberculosis complex. Int J Tuberc Lung Dis (2014) 18(5):594–600.10.5588/ijtld.13.0531 24903798 [OpenAIRE] [PubMed] [DOI]

11 Pas SD Koopmans MP Niedrig M. Clinical implications of and lessons learnt from external assessment of MERS-CoV diagnostics. Expert Rev Mol Diagn (2016) 16(1):7–9.10.1586/14737159.2016.1116943 26559930 [OpenAIRE] [PubMed] [DOI]

12 European Centre for Disease Prevention and Control. Euro-GASP External Quality Assessment (EQA) Scheme for Neisseria gonorrhoeae Antimicrobial Susceptibility Testing. Stockholm: ECDC (2017). Available from:

13 Zaki AM van Boheemen S Bestebroer TM Osterhaus AD Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med (2012) 367(19):1814–20.10.1056/NEJMoa1211721 23075143 [OpenAIRE] [PubMed] [DOI]

14 Corman VM Eckerle I Bleicker T Zaki A Landt O Eschbach-Bludau M Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill (2012) 17(39):20285.10.2807/ese.17.39.20285-en 23041020 [OpenAIRE] [PubMed] [DOI]

15 van Boheemen S de Graaf M Lauber C Bestebroer TM Raj VS Zaki AM Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio (2012) 3(6):e473–412.10.1128/mBio.00473-12 23170002 [OpenAIRE] [PubMed] [DOI]

56 references, page 1 of 4
Any information missing or wrong?Report an Issue